The Journal of Immunology, Vol 155, Issue 9 4397-4405, Copyright © 1995 by American Association of Immunologists

ARTICLES

Differential regulation of transforming growth factor beta-1 gene expression by glucocorticoids in human T and glial cells

OA Batuman, A Ferrero, C Cupp, SA Jimenez and K Khalili
Department of Medicine, SUNY Health Science Center, Brooklyn 11203, USA.

The inflammatory process in the brain requires bidirectional interaction of the immune and nervous systems. Evidently, astrocytic glial cells play an important role in facilitating this communication by releasing immunomodulators and cytokines. Expression of transforming growth factor beta-1 (TGF beta-1), a potent inhibitor of T cell function and glial cell proliferation, is highly regulated in T cells and is believed to be an important component in the molecular interaction between the immune and nervous systems. Comparative analysis of TGF beta-1 gene expression in human T and glial cells by Northern hybridization and S1 nuclease protection assay showed that dexamethasone (DM) caused a significant decrease in the basal and PMA- induced levels of TGF beta-1 mRNA in glial cells but not in T cells. This reduction correlated with a lower level of TGF beta-1 protein production. Transient transfection assay using deletion constructs of the 5' TGF beta-1 gene promoter-containing sequences between -453 and +11 bp identified a region spanning -160 to -60 bp as a potential sequence responsive to regulation by DM in T cells, whereas in glial cells, the overall transcriptional activity of the 5' TGF beta-1 promoter was reduced after DM treatment, but promoter activity within each construct remained constant in response to DM. Thus, a DM- responsive region could not be identified within the TGF beta-1 promoter in glial cells. These findings suggest that TGF beta-1 gene expression is differentially regulated by distinct regulatory elements in T and glial cells, and that extracellular stimulators, including glucocorticoids, can utilize the TGF beta-1-regulatory pathway to affect the functions of neural and immune cells.

This article has been cited by other articles:

				S. Cuzzocrea, S. Bruscoli, C. Crisafulli, E. Mazzon, M. Agostini, C. Muia, E. Esposito, R. Di Virgilio, R. Meli, E. Vegeto, et al. Estrogen Receptor Antagonist Fulvestrant (ICI 182,780) Inhibits the Anti-Inflammatory Effect of Glucocorticoids Mol. Pharmacol., January 1, 2007; 71(1): 132 - 144. [Abstract] [Full Text] [PDF]

				E. CALCAGNI and I. ELENKOV Stress System Activity, Innate and T Helper Cytokines, and Susceptibility to Immune-Related Diseases Ann. N.Y. Acad. Sci., June 1, 2006; 1069(1): 62 - 76. [Abstract] [Full Text] [PDF]

				A. K. Andersson, M. Chaduvula, S. E. Atkinson, S. Khanolkar-Young, S. Jain, L. Suneetha, S. Suneetha, and D. N. J. Lockwood Effects of Prednisolone Treatment on Cytokine Expression in Patients with Leprosy Type 1 Reactions Infect. Immun., June 1, 2005; 73(6): 3725 - 3733. [Abstract] [Full Text] [PDF]

				D FRANCHIMONT Overview of the Actions of Glucocorticoids on the Immune Response: A Good Model to Characterize New Pathways of Immunosuppression for New Treatment Strategies Ann. N.Y. Acad. Sci., June 1, 2004; 1024(1): 124 - 137. [Abstract] [Full Text] [PDF]

				I. J. ELENKOV Glucocorticoids and the Th1/Th2 Balance Ann. N.Y. Acad. Sci., June 1, 2004; 1024(1): 138 - 146. [Abstract] [Full Text] [PDF]

				I. J. ELENKOV and G. P. CHROUSOS Stress Hormones, Proinflammatory and Antiinflammatory Cytokines, and Autoimmunity Ann. N.Y. Acad. Sci., June 1, 2002; 966(1): 290 - 303. [Abstract] [Full Text] [PDF]

				H. O. Akman, H. Zhang, M. A. Q. Siddiqui, W. Solomon, E. L. P. Smith, and O. A. Batuman Response to hypoxia involves transforming growth factor-beta 2 and Smad proteins in human endothelial cells Blood, December 1, 2001; 98(12): 3324 - 3331. [Abstract] [Full Text] [PDF]

				R. W. BAKER, B. R. WALKER, R. J. SHAW, J. W. HONOUR, D. S. JESSOP, S. L. LIGHTMAN, A. ZUMLA, and G. A. W. ROOK Increased Cortisol . Cortisone Ratio in Acute Pulmonary Tuberculosis Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1641 - 1647. [Abstract] [Full Text]